Search clinical trials for: Amlodipine Olmesartan medoxomil
Total 767 results
-
Nara Medical UniversityCompleted
-
XueQing YuRecruitingDiabetes Mellitus, Type 2 | Prehypertension | Blood Pressure | Cardiovascular Risk Factor | Adverse EventChina
-
Chong Kun Dang PharmaceuticalCompleted
-
Third Military Medical UniversityCompleted
-
NovartisCompletedStage 2 Systolic HypertensionUnited States
-
Sirion Therapeutics, Inc.CompletedInflammationUnited States
-
TakedaCompleted
-
Lee's Pharmaceutical LimitedCompleted
-
University of UtahBoston University; University of Pennsylvania; Northwestern University; Columbia... and other collaboratorsCompleted
-
University of PaviaUnknownEssential HypertensionItaly
-
Lee's Pharmaceutical LimitedZhaoke (Guangzhou) Pharmaceutical LimitedCompletedBioequivalence of Two Azilsartan FormulationsHong Kong
-
Jeil Pharmaceutical Co., Ltd.CompletedHypertension With DyslipidemiaKorea, Republic of
-
University of Roma La SapienzaUnknown
-
Northwestern UniversityNational Heart, Lung, and Blood Institute (NHLBI); American Society for TransplantationWithdrawnHigh Blood Pressure | Liver Transplant | Renal Function AbnormalUnited States
-
Seoul National University HospitalDong-A Pharmaceutical Co., Ltd.CompletedRaynaud PhenomenonKorea, Republic of
-
Ono Pharmaceutical Co. LtdCompletedAdvanced Solid Tumors | Recurrent Solid TumorsKorea, Republic of
-
George Medicines PTY LimitedCompletedHypertensionAustralia, United States, Nigeria, Sri Lanka, United Kingdom
-
IlDong Pharmaceutical Co LtdCompletedHypertension With HyperlipidemiaKorea, Republic of
-
Jing LiuBayerTerminated
-
Overseas Pharmaceuticals, Ltd.Guangzhou Health Start Pharmaceutical Techology Co.,LtdNot yet recruiting
-
Jeil Pharmaceutical Co., Ltd.CompletedHypertension With DyslipidemiaKorea, Republic of
-
NovartisCompletedHypertensionSwitzerland, Germany
-
NovartisCompleted
-
Chong Kun Dang PharmaceuticalCompleted
-
BayerCompleted
-
University of ManitobaSuspended
-
Yonsei UniversityTerminatedPeripheral Artery Disease With Intermittent ClaudicationKorea, Republic of
-
TakedaRecruiting
-
Ono Pharmaceutical Co. LtdCompletedMalignant Solid TumorJapan
-
NovartisCompleted
-
NovartisCompleted
-
NovartisPfizerCompletedHypertensionUnited States
-
NovartisCompleted
-
HK inno.N CorporationUnknownHypertension | HyperlipidemiaKorea, Republic of
-
Novartis PharmaceuticalsBaker Heart and Diabetes InstituteCompletedHypertensionUnited States, Australia
-
Second Affiliated Hospital, School of Medicine,...RecruitingDiabetic Kidney Disease | Proteinuria | Blood Pressure | Kidney DysfunctionChina
-
NovartisCompletedHYPERTENSIONSwitzerland, Germany
-
Handok Inc.CompletedEssential HypertensionKorea, Republic of
-
Boehringer IngelheimCompletedHypertensionKorea, Republic of
-
National Institute of Neurological Disorders and...Completed
-
NovartisCompletedHypertensionUnited States, Germany
-
NovartisCompletedHypertension | Left Ventricular HypertrophyUnited States
-
Novartis PharmaceuticalsCompletedHypertension | Concurrent ObesityGermany, Netherlands
-
Overseas Pharmaceuticals, Ltd.Guangzhou Kangqi Medical Technology Co., LTDActive, not recruiting
-
NovartisCompletedHypertensionSwitzerland, Germany
-
Boryung Pharmaceutical Co., LtdCompletedDrug-Drug InteractionKorea, Republic of
-
Novartis PharmaceuticalsWithdrawn
-
Boehringer IngelheimCompletedHypertensionUnited States, Argentina, Korea, Republic of, Mexico, Netherlands, Slovakia, South Africa, Spain, Sweden
-
SanofiCompletedIrbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Irbesartan 150 mg Monotherapy (I-ADD)HypertensionMorocco, Brazil, Colombia, Guatemala, Mexico, Tunisia, United Arab Emirates, Venezuela